Evidence map›Paper›PMID 27657745›Full record

ArticleCell cycle (Georgetown, Tex.)2016

Cyclin A2 regulates erythrocyte morphology and numbers.

Senthil Raja Jayapal, Heather Yin-Kuan Ang, Chelsia Qiuxia Wang, Xavier Bisteau, Matias J Caldez, Gan Xiao Xuan, Weimiao Yu, Vinay Tergaonkar, Motomi Osato, Bing Lim and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Erythroblast enucleation at a glance.Journal of cell science · 2024
    Review
  4. CDK4/6 inhibitor-induced bone marrow micronuclei might be caused by cell cycle arrest during erythropoiesis.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Senthil Raja Jayapala Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Heather Yin-Kuan Angb Genome Institute of Singapore , Singapore.
Chelsia Qiuxia Wanga Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Xavier Bisteaua Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Matias J Caldeza Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Gan Xiao Xuana Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Weimiao Yua Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Vinay Tergaonkara Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Motomi Osatoc Cancer Science Institute of Singapore, National University of Singapore , Singapore.
Bing Limb Genome Institute of Singapore , Singapore.
Philipp Kaldisa Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research) , Singapore , Republic of Singapore.
Institute of Molecular and Cell Biology · SGAgency for Science, Technology and Research · SGGenome Institute of Singapore · SGNational University Cancer Institute, Singapore · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclin A2 is an essential gene for development and in haematopoietic stem cells and therefore its functions in definitive erythropoiesis have not been investigated. We have ablated cyclin A2 in committed erythroid progenitors in vivo using erythropoietin receptor promoter-driven Cre, which revealed its critical role in regulating erythrocyte morphology and numbers. Erythroid-specific cyclin A2 knockout mice are viable but displayed increased mean erythrocyte volume and reduced erythrocyte counts, as well as increased frequency of erythrocytes containing Howell-Jolly bodies. Erythroblasts lacking cyclin A2 displayed defective enucleation, resulting in reduced production of enucleated erythrocytes and increased frequencies of erythrocytes containing nuclear remnants. Deletion of the Cdk inhibitor p27

Indexed as

Cell ShapeAnimalsBone Marrow CellsBromodeoxyuridineCell CountCell CycleCell NucleusCells, CulturedCyclin A2Cyclin-Dependent Kinase Inhibitor p27DNA DamageErythrocytesErythroid CellsErythropoiesisGreen Fluorescent ProteinsIntegrasesBromodeoxyuridineCre recombinaseCyclin A2Cyclin-Dependent Kinase Inhibitor p27Green Fluorescent ProteinsIntegrasesReceptors, ErythropoietinAnimal modelsBFU-E coloniesCFU-E coloniesCyclin A2CyclinsDNA damage and repairenucleationerythropoiesisG1/S transitionHematopoiesisHowell-Jolly bodiesProtein kinasesStem cells

Identifiers

PMID27657745
PMCPMC5134699
OpenAlexW2523065272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.